1 year return (CAGR)
-85.71%
Navidea Biopharmaceuticals Inc. Exchange (NASDAQ, USD)
NAVBQ
0.00
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-93.07%
5 year return (CAGR)
-86.79%
10 year return (CAGR)
-59.80%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
10.01K
Price/Sales
16.41
Ent value
4.82M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.00 |
| Daily high | 0.00 |
| Daily low | 0.00 |
| Daily Volume | 2K |
| All-time high | 5.48 |
| 1y analyst estimate | - |
| Beta | 54.83 |
| EPS (TTM) | -0.01 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 25 Mar 2026 |
Downside potential
Loading...
Downside potential data
| NAVBQ | S&P500 | |
| Current price drop from All-time high | -100.00% | -1.29% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 14 Jan 2026 | 9 Mar 2009 |
| Avg drop from high | -77.40% | -10.68% |
| Avg time to new high | 178 days | 12 days |
| Max time to new high | 3705 days | 1805 days |
News
